COGNICURRENT

Feb 4 • 10:42 UTC • 🇳🇬 Nigeria • Punch

GSK profit rises to £5.7bn as speciality medicines drive growth

GSK's net profit surged to £5.7 billion, primarily fueled by strong sales in specialty medicines like HIV and cancer drugs, as the company rebounds from previous legal challenges.

#gsk #pharmaceuticals #profit #specialty medicines

Read Original Back to Feed

📡 Similar Coverage

🇳🇬 Nigeria Feb 10 • 10:50 UTC

AstraZeneca profit rises as cancer drug sales grow

Punch

🇬🇧 UK Feb 10 • 12:26 UTC

AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

Guardian

🇮🇹 Italy Feb 12 • 04:00 UTC

For Banca Generali, record profits. Move: "New phase"

Il Giornale

🇧🇷 Brazil Feb 9 • 12:15 UTC

BTG Pactual increases profit by 40.3% in one year and reaches R$ 4.6 billion in the 4th quarter

Folha (PT)

🇬🇧 UK Feb 24 • 14:01 UTC

AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

Guardian

🇬🇷 Greece Feb 16 • 15:24 UTC

The fastest-growing pharmaceutical companies invest in innovation

Naftemporiki